My plan is to tell my siblings, aunts and uncles that we have a sufficient history of cancer in our family to qualify for genetic testing and that they should discuss it with their doctors if ...

More information: Marco Galimberti et al, The genetic relationship between cannabis use disorder, cannabis use and psychiatric disorders, Nature Mental Health (2025).

Tailoring medicines to an individual’s genetic profile is now possible. One critical aspect is genetic testing that reduces side effects, particularly for patients on psychiatric and cardiovascular ...

The U.S. Food and Drug Administration has approved Andembry (garadacimab-gxii) as the only treatment targeting factor XIIa for prophylactic use to prevent attacks of hereditary angioedema (HAE).

Hereditary leiomyomatosis and renal-cell cancer (HLRCC) is an inherited disorder characterized by germline pathogenic variants in the gene encoding fumarate hydratase and an increased risk of papil ...

Garadacimab-gxii is the first and only treatment that targets factor XIIa (FXIIa) for the prophylactic prevention of hereditary angioedema (HAE) attacks in patients 12 years and older.

The antibody-based drug Andembry is the first to target factor XIIa, a protein responsible for swelling in people with this rare genetic disorder.

The FDA has approved Andembry for prophylactic use to prevent attacks of HAE in adult and pediatric patients aged 12 years and older.

Genetic variant tied to doubled dementia risk for older men Researchers looked at a gene that is critical to regulating the body’s iron levels.

The genetic testing company 23andMe is poised to be sold to a nonprofit run by the company's former chief executive Anne Wojcicki.

Bankrupt 23andMe is facing a lawsuit over its plans to sell customer genetic information.

Twenty-seven states and the District of Columbia have sued the bankrupt genetic testing company 23andMe in an effort to block the company's sale of its customers' genetic data.